Student Research Committee, Department of Clinical Nutrition, School of Nutrition and Food Science, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Orthopedics, Isfahan University of Medical Sciences, Isfahan, Iran.
Complement Ther Med. 2020 Nov;54:102535. doi: 10.1016/j.ctim.2020.102535. Epub 2020 Aug 9.
The objective of the present study was to perform a systematic review and meta-analysis on randomized controlled trials (RCTs) assessing the effects of Nigella sativa L. supplementation on the circulating inflammatory and oxidative stress markers, including C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), total antioxidant capacity (TAC) and malondialdehyde (MDA).
Systematic search was performed up to March 2020 using PubMed, Scopus, and ISI web of science databases. Two reviewers independently assessed study eligibility, extracted data, and evaluated methodological quality of included primary studies. Statistical heterogeneity was assessed using I-square (I) statistic. Data were pooled by using the random-effect model and standardized mean difference (SMD) was considered as the summary effect size.
Twelve trials were identified to be suitable for our meta-analysis. The pooled results using random effects model indicated that Nigella sativa supplementation significantly reduced CRP (SMD: -0.35; 95% CI: -0.59, -0.12, P < 0.001, I = 10.5%) and MDA concentrations (SMD: -0.56; 95% CI: -0.98, -0.15, P < 0.001, I = 64.7%). Moreover, Nigella sativa supplementation increased TAC (SMD: 0.48; 95% CI: 0.09, 0.87, P = 0.01, I = 65.6%) levels; however, it did not affect TNF-α (SMD: -0.35; 95% CI: -0.70, 0.01, P = 0.05, I = 58.2%).
Nigella sativa supplementation is associated with improved inflammation and oxidative status. Additional prospective studies are recommended using higher supplementation doses and longer intervention period.
本研究旨在对评估黑种草(Nigella sativa L.)补充剂对循环炎症和氧化应激标志物(包括 C 反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、总抗氧化能力(TAC)和丙二醛(MDA))影响的随机对照试验(RCT)进行系统评价和荟萃分析。
系统检索至 2020 年 3 月,检索数据库包括 PubMed、Scopus 和 ISI web of science。两名评审员独立评估研究入选标准、提取数据并评估纳入的原始研究的方法学质量。使用 I 平方(I)统计量评估统计异质性。使用随机效应模型汇总数据,采用标准化均数差(SMD)作为汇总效应量。
确定 12 项试验适合我们的荟萃分析。使用随机效应模型的汇总结果表明,黑种草补充剂可显著降低 CRP(SMD:-0.35;95%CI:-0.59,-0.12,P < 0.001,I = 10.5%)和 MDA 浓度(SMD:-0.56;95%CI:-0.98,-0.15,P < 0.001,I = 64.7%)。此外,黑种草补充剂可增加 TAC(SMD:0.48;95%CI:0.09,0.87,P = 0.01,I = 65.6%)水平;然而,它对 TNF-α 没有影响(SMD:-0.35;95%CI:-0.70,0.01,P = 0.05,I = 58.2%)。
黑种草补充剂与改善炎症和氧化状态有关。建议进行更多使用更高补充剂量和更长干预时间的前瞻性研究。